The CHPF Antibody (PACO08417) is a high-quality polyclonal antibody designed for research involving CHPF, a protein involved in glycosylation and cell signaling processes. This antibody, raised in rabbits, is specifically reactive with human CHPF samples and has been validated for use in applications such as Western blot and immunofluorescence.CHPF plays a crucial role in protein glycosylation, a post-translational modification that is essential for proper protein function and cell signaling. Dysregulation of glycosylation processes has been implicated in various diseases, making CHPF a potential target for therapeutic intervention.
By using the CHPF Antibody, researchers can study the expression and localization of CHPF in different cell types, providing valuable insights into its function and potential implications in disease states.This antibody is an invaluable tool for studies in glycobiology, cell biology, and disease mechanisms related to aberrant glycosylation. With its high specificity and sensitivity, the CHPF Antibody offers researchers a reliable means of investigating the role of CHPF in health and disease, paving the way for new therapeutic strategies and treatment options.
CHPF: a type II transmembrane protein. May act as a specific activating factor for chondroitin synthase in chondroitin biosynthesis and polymerization. Protein type: Glycan Metabolism - chondroitin sulfate biosynthesis; EC 2.4.1.226; EC 2.4.1.175; Membrane protein, integral; TransferaseChromosomal Location of Human Ortholog: 2q35Cellular Component: Golgi membraneMolecular Function: glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activityBiological Process: chondroitin sulfate biosynthetic process
